Barnatron is the licence holder and manufacturer of Barnascan 3000 MBq/ml solution for injection and manufacturer of Fluorscan 1700 MBq/ml and Fluorscan 3000 MBq/ml. The three pharmaceutical products contain the active substance [18F]-fluorodeoxyglucose and are distributed in 10 ml multi-dose vials. The normal recommended activity per adult dose is 185 to 370 MBq.
a) Production of [18F-]-labelled radiopharmaceuticals:
Sodium fluoride Na [18F], for bone studies; Thymidine [18F]-FLT and [18F] FDDNP with application in the field of oncology and Alzheimer’s disease.
b) Production of 11C-labelled radiopharmaceuticals: [11C]-Choline, [11C]-Methionine and [11C]-Flumazenil with application in the field of oncology and neurology.
c) Production of [18F2-18F-]-labelled radiopharmaceuticals: [18F-]-DOPA with application in diseases related with movement disorders.
Information recarding requests
Requests for doses of Barnascan 3000 MBq/ml, Fluorscan 1700 MBq/ml and Fluorscan 3000 MBq/ml solutions for injection, containing the active substance [18F]-fluorodeoxyglucose, should be made by fax or e-mail, indicating the number of doses requested and their time of administration.
In general, requests for doses should be made no later than on the previous day. Barnatron will respond to requests made in subsequent hours.
In general, requests for doses should be made no later than on the previous day. However, Barnatron may occasionally respond to requests made in subsequent hours.
Urgent doses: Barnatron can deliver doses on the same day as administration but only following prior telephone consultation.